BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Avian flu virus
,
Fluoxetine
,
rs2230926
,
TGFB1
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
serotonin binding
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Prefrontal cortex
Pons
Dendritic (plasmacytoid) cell
Spleen
Appendix
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Obsessive-compulsive disorder
Infestation by Sarcoptes scabiei var canis
Vesicular stomatitis Indiana virus disease
Alpha-1-antitrypsin deficiency
Myocardial ischemia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
eletriptan
minaprine
CGP 60474
mirtazapine
ziprasidone
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SHANK3
NISCH
PPP2R2C
DMD
NR5A1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Serotonin-transporter-linked promoter region polymorphism and serotonin transporter binding in drug-…
Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder.
Serotonergic drugs modulate the phase behavior of complex lipid bilayers.
Reduced amygdala serotonin transporter binding in posttraumatic stress disorder.
Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-1006…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Investigation of Serotonin Receptor Binding in the Migraine Brain Using Positron Emission Tomography
Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter
Effects of Electroconvulsive Therapy (ECT) on Serotonin-1A Receptor Binding
Serotonin in Alcoholism
Sex Steroids and the Serotonin Transporter
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ